---

Pharmacists Rightly Concerned about Women’s Health and Plan B

LifeSiteNews.com staff

TORONTO, December 2, 2005 (LifeSiteNews.com) - Guidelines from the Canadian Pharmacists Association advise pharmacists to collect a woman’s name, address, phone number and details about her sexual activity before they dispense the so-called “morning-after pill”. After Heath Canada made levonorgestral or Plan B an over the counter drug, the pharmacists association posted guidelines which suggested a screening of the patient.

Women groups such as the Canadian Women’s Health Network are asking that the drug be made available in grocery and variety stores in order to protect women’s privacy.

“This drug is a double dose birth control pill which is a hazard to women’s health. Even the regular birth control pill causes blood clots and strokes,” said Jim Hughes, National President of Campaign Life Coalition (CLC).”The morning-after pill also prevents the newly conceived child from implanting in the uterus, resulting in the death of the child. Promoters are trying to deceive the public into believing that this is not an abortifacient and that it is safe for women.”

“It would seem to me that women’s groups should be happy that pharmacists are more concerned about a woman’s health then their groups are. The pharmacists are very wise in taking these precautions for the dispensing of such dangerous medication,” said Mary Ellen Douglas, National Organizer for CLC. “If Health Canada and the women’s groups do not understand the risk that women are taking with these drugs, the pharmacists do and they
are not about to be sued,” she continued.

 Back to Top

---

MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.